Sharing research material between colleagues looks like a courtesy. In practice it is a small compliance project. The moment a second person draws from the same vial, the purchaser’s responsibilities — lawful use, safe handling, correct storage, documented disposal and a COSHH assessment that actually matches the work — are no longer exercised by one person in one place. They are exercised twice, often in different rooms, under different project pressures, and occasionally under different supervisors. Getting that arrangement right is less about trust and more about documentation, naming and a shared record that survives a change of shift.
Why Shared Stock Is a Compliance Question Before It Is a Storage Question
Research-use-only supply is designed to move a material from a supplier’s shelf into a controlled laboratory workflow — it does not move responsibility with it. Research Sciences states that its materials are supplied strictly for controlled laboratory and analytical research, that they are not medicines, medical devices, injectables, treatments or food supplements under UK law, and that the buyer is responsible for lawful use, safe handling, storage, disposal and compliance with regulations including COSHH and laboratory safety standards. Once two colleagues decide to draw from the same stock, that single purchaser responsibility becomes a shared operational one, and the paperwork has to survive the split.
The first thing to separate is documentation from physical stock. Vial labels carry a reference combining the SKU code and an expiry date — the shop’s format example is BPC10-03/27 — and that reference links to the corresponding Certificate of Analysis. If two researchers ordered at different times, they may each hold a CoA for what looks like identical material. The shop’s FAQ notes that restocked products may carry the same Internal Test Reference (ITR) as earlier stock, and that an ITR links to associated sample testing reports without confirming that separate deliveries came from the same production lot or underwent separate independent testing. Cap colours and other packaging may also vary, and are explicitly not an indicator of identity, analytical quality or manufacturing origin.
The practical implication is straightforward: agree, in writing, which batch documentation governs the shared stock. If the two colleagues are holding vials from two deliveries, treat them as two stocks with two records rather than one pool. Where the shop lists CoAs Janoshik Analytical Reports on its homepage and states that every product includes a CoA covering purity and identity by HPLC, the working assumption should still be that the specific batch document in front of you is the authoritative one — open it, read it, and file it against the vial reference.
It is also worth restating the label position as the shop describes it: products are marked “For Research Use Only – Not for Human Consumption”, a stance the shop presents as being in line with MHRA guidance. That is the supplier’s stated position, not legal advice, and it does not soften on the bench. These materials are not for human or veterinary use, and nothing about a shared-stock arrangement changes that.
Building a COSHH Assessment Two People Can Actually Follow
COSHH assessments fail most often not because they are wrong but because they are written for one person’s habits. A shared-stock assessment has to describe the activity rather than the individual. Cover the substance and its form — many catalogue items are lyophilised powders, and the shop’s FAQ notes that all peptides contain trace amounts of mannitol as an excipient — together with the quantities held, the people exposed, the controls in place, the storage location, spillage response, waste route and emergency arrangements. Then name both colleagues as authorised users, with a deputy for absences.
Storage controls should be identical for both users, because inconsistency is where shared stock degrades. The shop’s handling guide is the sensible baseline: allow vials to reach room temperature before opening, work in a clean environment, remove only the amount required for the experiment, store lyophilised material at −20 °C or below, sealed with desiccant and protected from moisture, heat and light, and avoid repeated freeze–thaw cycles. Reconstituted material is less stable and should be held at 2–8 °C for short-term laboratory use. Both colleagues need to know where the desiccant lives and who replaces it.
Reconstitution belongs firmly inside an in-vitro workflow. Diluent volume and target concentration are calculated for the assay, not for anything else, and the shop’s free reconstitution calculator is described for laboratory research use only — it must not be used for human or veterinary dosing. Where a colleague is preparing material for a cell-based or analytical assay, the assessment should record the diluent, the concentration range, the vessel and the disposal route. Again, these materials are not for human or veterinary use, and the assessment should say so on its face so that nobody joining the project later misreads the intent.
Finally, treat the arrival of a second user as a change of circumstances that triggers a review. New bench space, a new freezer, a different waste stream or an additional assay type are all reasons to revisit the assessment rather than assume the original still holds.
Custody, Records and the Paper Trail Between Two Colleagues
A shared stock log is the single most useful control a laboratory can introduce, and it need not be elaborate. Record the date received, the label reference, the CoA and ITR cited on that document, the storage location, the quantity removed on each occasion, the number of freeze–thaw cycles the vial has seen, any temperature excursion, and the name of the person who took custody. Where a vial physically moves between benches or between sites, log the transfer. Where a colleague leaves the project, log the handover.
The same discipline applies whether the material is being reordered through Peptides uk or being carried across from an earlier delivery: the CoA filed against the vial is the one that governs, and it should be checked on receipt and again before first use rather than assumed from a previous order. When querying documentation, quote the label reference — the SKU and expiry combination — so the shop can identify the exact batch. That single habit prevents most of the confusion that arises when two people believe they are describing the same stock.
Ordering and payment arrangements have a bearing too. Research Sciences describes Pay-By-Bank / Open Banking through regulated providers rather than card payments, and states that it does not store bank login details. In a shared-stock situation, decide up front which colleague holds the order record and the accompanying documentation, so that a CoA is not stranded in a personal inbox when the other researcher needs it during an audit or an internal review. Fulfilment terms — next-working-day dispatch, tracked domestic delivery and temperature-aware storage as described on the site — should be reconfirmed at checkout, along with the current published purity wording, rather than carried forward from memory.
None of this is bureaucratic decoration. The log and the filed CoA are the evidence that the purchaser’s responsibilities were discharged by both people, not just the one whose name sat on the order. Materials remain not for human or veterinary use, the supplier provides no therapeutic, clinical, dosing or injection guidance, and suitability for a given research application stays with the laboratory. A short written agreement between two colleagues — documentation, storage, custody, review — is usually all that separates a well-run shared stock from an untraceable one.
Florence art historian mapping foodie trails in Osaka. Chiara dissects Renaissance pigment chemistry, Japanese fermentation, and productivity via slow travel. She carries a collapsible easel on metro rides and reviews matcha like fine wine.
